An alarming rise in the incidence of blood disorders such as anaemia, leukocytosis, haemophilia, and Von Willebrand Disease has become a core concern for people. Von Willebrand Disease (VWD) is a disease in which blood doesn't clot properly, causing fatal bruises. Noticeably, geriatric population is more susceptible to VWD. This has generated substantial demand for anti-inflammatory and anticoagulant drugs. In addition, with people turning toward healthier lifestyles, there has been an upsurge in physical and sports activities. Due to intense workout sessions, individuals often develop bruises, strain, and sore muscles which need prompt treatment. As a result, there has been a momentous rise in the demand for bruise treatment. Such a landscape is fostering the ground for the global bruise treatment market to expand and grow throughout the projection period.
For More Industry Insights Read: https://www.fairfieldmarketresearch.com/report/bruise-treatment-market
Soaring Prevalence of Haemophilia to Bolster Bruise Treatment Market Growth Prospects
Centres of Disease Control and Prevention (CDC) recently reported that 1 in every 5000 males are likely to develop haemophilia. Among these, almost 60% of individuals suffering from haemophilia A are in a critical phase. Such an incessant rise in the prevalence of haemophilia has surged the number of bruises at a global level. Haemophilia is a rare blood disorder, wherein, due to lack of blood-clotting proteins the blood fails to clot properly. To this end, minor bumps or even minor scratches might lead to significant bruises. This puts forth the need for various drugs including anti-inflammatory and anticoagulant medications efficiently treat and heal these bruises. Against such a backdrop, the bruise treatment market is pivotally positioned to expand and prosper on the global front.
Anti-Inflammatory Drugs to Unlock Fresh Revenue Streams for Bruise Treatment Market
The critical inflammation caused by bruises often leads to complexities and discomfort. As a result, people may feel severe pain, swelling, and redness along with loss of function. Essentially, nonsteroidal anti-inflammatory drugs (NSAIDs) help in easing pain, swelling, and other such conditions. Their ability to relieve pain, headaches, and sprains has gained notable traction in bruise treatments. That’s why these anti-inflammatory drugs are widely mentioned in post-injury prescriptions. Over-the-counter (OTC) availability of these NSAIDs has garnered tremendous popularity and boosted sales of anti-inflammatory drugs including aspirin, heparin, ibuprofen, warfarin, and clopidogrel. Against this backdrop, burgeoning sales of anti-inflammatory drugs are creating headways for the global bruise treatment expansion, generating a subsequent influx of revenue.
North America Spearheads Growth Owing to Sustained Demand for Bruise Treatment & Growing Geriatric Population
Almost 1% of the US population is affected by Von Willebrand Disease. Approximately, 1.38 individuals per million in North America are suffering from Von Willebrand Disease type 3. Such an alarming rise in the incidence of blood disorders and the growing geriatric population have elevated the demand for bruise treatment in the region. Furthermore, growing awareness regarding bruises and well-established healthcare infrastructure has surged R&D activities in the pharmaceutical and biotechnology domains. Under such circumstances, North America is set to scale dominance across the global bruise treatment market.
Key Market Players
Some of the most prominent players operating in the global bruise treatment market include Pharmavite LLC, Bioderma, Zealous Health Private Limited, Arnicare Boiron, TriDerma, Stada Arzneimittel AG, and Topix Pharmaceuticals Inc.
For More Information Visit: https://www.fairfieldmarketresearch.com/report/bruise-treatment-market
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
